[1]
“Fvc, Fev1 and Fev1/Fvc % in Female SLE Patients and Their Relationship with Duration of the Disease”, Med. Today, vol. 26, no. 1, pp. 22–27, Dec. 2014, doi: 10.3329/medtoday.v26i1.21307.